William R. Larue

William R. Larue, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Tracon Pharmaceuticals, Inc. and Oncternal Therapeutics, Inc. Over a trading history stretching from 1 June 2016 to 21 December 2022, the count stands at 6 filings.

Both buying and selling appear: 1 purchase worth €21k, against 2 sales worth €6,138. The net balance comes to €15k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants. In 2023 alone, the filings show no purchases and 1 sale.

The latest filing, published on 19 January 2023, reports an open-market sale of €142 in Tracon Pharmaceuticals, Inc. The last insider purchase was made public on 27 July 2021, 1,915 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.